1982
DOI: 10.1016/0092-8674(82)90090-3
|View full text |Cite
|
Sign up to set email alerts
|

Membrane insertion and oligomeric assembly of HLA-DR histocompatibility antigens

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

12
165
2
1

Year Published

1984
1984
2013
2013

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 296 publications
(180 citation statements)
references
References 36 publications
12
165
2
1
Order By: Relevance
“…DR 3' chains present in the oligomeric complex with DR a and/3 moieties undergo intracellular transport and, subsequently, are detached from the oligomeric complex that finally appears on the cell surface (9,14). The ultimate fate of the DR 3' chain is unknown.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…DR 3' chains present in the oligomeric complex with DR a and/3 moieties undergo intracellular transport and, subsequently, are detached from the oligomeric complex that finally appears on the cell surface (9,14). The ultimate fate of the DR 3' chain is unknown.…”
Section: Resultsmentioning
confidence: 99%
“…HLA-DR antigens represent the human analogue to murine I-E antigens (6), whereas HLA-DS (7) or DC 1 antigens (8) correspond to murine I-A molecules. HLA-DR oligomers are formed by the noncovalent association of three po]ypeptides, i.e., a, /3, and 3' chains (9). As opposed to a and/3 chains the 3' chain appears to be invariant, at least by charge and mass, regardless of the DR phenotype (10,11).…”
mentioning
confidence: 99%
“…This shows that trimerization is not induced by the N-terminal cytosolic tail although NMR studies have shown that a peptide representing the tail is found as a homotrimer. 2 Various chemical cross-linkers were generally needed to stabilize the multimers, but trimers of p35* hIi, p33 hIi, and ⌬20 hIi were also detected under nonreducing conditions without the use of cross-linker. This might indicate that parts of the cytosolic tail of Ii have a stabilizing effect on the trimer after its induction.…”
Section: Discussionmentioning
confidence: 99%
“…Invariant chain (Ii) is a type II transmembrane protein that associates with the major histocompatibility complex (MHC) class II molecules in the endoplasmic reticulum (ER) (1,2). The formation of the ␣␤Ii complex occurs by the sequential addition of one ␣-and one ␤-chain to a pre-existing core of trimeric Ii molecules (3,4).…”
mentioning
confidence: 99%
“…Ii binds the MHCII peptide-binding groove with a region in its luminal domain that is called CLIP (for class-II-associated invariant chain peptide) (Rudensky et al 1991;Chicz et al 1992;Riberdy et al 1992;Sette et al 1992;Freisewinkel et al 1993). Normally, Ii is synthesized in excess over MHCII, ensuring Ii rather than peptide binding to MHCII (Kvist et al 1982;Sekaly et al 1986;Marks et al 1990;Pieters et al 1991). Peptides that are transferred into the ER by TAP, for potential binding to MHCI, indeed have poor potential to bind MHCII (Bikoff et al 1993;Viville et al 1993;Elliott et al 1994;Romagnoli and Germain 1994;Busch et al 1996).…”
Section: Biosynthesis Of Mhciimentioning
confidence: 99%